Gemcitabine Hydrochloride Related Compounds & Impurities

Gemcitabine Hydrochloride is a nucleoside analogue antimetabolite that inhibits DNA synthesis, used for pancreatic, non-small cell lung, bladder and breast cancers.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Gemcitabine Hydrochloride reference standards, pharmacopeial and non-pharmacopeial Gemcitabine Hydrochloride impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Gemcitabine Hydrochloride-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Gemcitabine Hydrochloride
Gemcitabine EP Impurity A
Gemcitabine EP Impurity C
Gemcitabine EP Impurity B Hydrochloride
4-Hydroxy-3,4-dihydro-gemcitabine
1-(3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)6-hydroxydihydropyrimidine-2,4(1H,3H)-dione
Gemcitabine Impurity 4
10-amino-5,5-difluoro-4-hydroxy-3,4,5,6,9,11a-hexahydro-3,6-epoxypyrimido[6,1-b][1,3]oxazocin-8(2H)-one
2-Deoxy-2,2-difluoro-D-erythro-ribofuranose-3,5-dibenzoate 1-Methanesulfonate
2`-Deoxy-3`,5`-di-O-benzoyl-2`,2`-difluorocytidine
((2R,3R,5R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate
3`-Epi Gemcitabine
Gemcitabine Impurity 9
Gemcitabine Impurity 10
Gemcitabine 5-benzoate
Gemcitabine 3-benzoate
Gemcitabine
(3R,4R)-1-ethoxy-2,2-difluoro-4,5-dihydroxy-1-oxopentan-3-yl benzoate
(R)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-ethoxy-2,2-difluoro-3-oxopropyl benzoate
Gemcitabine Impurity 15
Gemcitabine Impurity 21
(R)-Glyceraldehyde acetonide
Gemcitabine Impurity 11
Gemcitabine Impurity 19
2-Deoxy-2,2-difluoro-D-erythro-pentofuranose
3,3,difluoro 4- hydroxy-5-(hydroxyl methyl) dihydrofuran-2(3H)-one
Gemcitabine Impurity 12
Gemcitabine Impurity 29
1`-Epi Gemcitabine 3`,5`-Dibenzoate
3`-Epi Gemcitabine 3`,5`-Dibenzoate
Gemcitabine Impurity 31
Gemcitabine EP Impurity B
Gemcitabine Impurity 35 Hydrochloride
Gemcitabine Impurity 1
Gemcitabine Impurity 5
Gemcitabine Impurity 6
Gemcitabine Impurity 2

Metabolites

Gemcitabine triphosphate

Isotope Labelled Compounds

Gemcitabine-13C-15N2
Gemcitabine EP Impurity C-13C,15N2
Gemcitabine 13C,15N2 Hydrochloride